Quanterix Corporation header image

Quanterix Corporation

QTRX

Equity

ISIN null / Valor 39127916

NASDAQ (2026-05-18)
USD 2.52-8.36%

Quanterix Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Quanterix Corporation is a company focused on transforming healthcare by enhancing the precision and understanding of health to disease progression through advanced scientific research. It operates at the forefront of the healthcare industry, leveraging a combination of experienced management, leading scientists, and strategic investments to push the boundaries of precision health science. The company has established a significant global presence, serving hundreds of academic and industry clients with direct sales in North America and parts of Europe, while also reaching a wider international market through distributor partnerships. Quanterix offers a range of products and services designed to support the research needs of its customers, backed by a dedicated team of field application scientists and engineers providing comprehensive customer support worldwide. This approach underscores the company's commitment to advancing healthcare research and diagnostics through innovative technology and collaborative efforts.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-47.4%1Y
-86.0%3Y
-94.7%5Y

Performance

79.5%1Y
71.9%3Y
82.5%5Y

Volatility

Market cap

119 M

Market cap (USD)

Daily traded volume (Shares)

1,505,053

Daily traded volume (Shares)

1 day high/low

11.04 / 10.715

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 523134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.87%USD 22.22
Coty Inc
Coty Inc Coty Inc Valor: 1645885
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.43%USD 2.01
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.22%USD 55.12
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.89%USD 144.37
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 982352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.57%GBP 137.10
Alignment Healthcare Inc
Alignment Healthcare Inc Alignment Healthcare Inc Valor: 110387702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.50%USD 16.28
TransMedics Group Inc
TransMedics Group Inc TransMedics Group Inc Valor: 47361695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.13%USD 68.34
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc Valor: 56295735
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.86%USD 29.83
Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc Valor: 115580129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.20%USD 12.86
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 43.22